Literature DB >> 28478090

Parotid adenoid cystic carcinoma: Retrospective single institute analysis.

Giuditta Mannelli1, Lorenzo Cecconi2, Martina Fasolati3, Roberto Santoro3, Alessandro Franchi4, Oreste Gallo3.   

Abstract

PURPOSE: Adenoid cystic carcinoma (ACC) is a uncommon salivary malignant tumor. Our aim was to review our experience with parotid ACC, to identify clinical-pathological parameters predictive for outcome.
MATERIALS AND METHODS: We retrospectively reviewed 228 patients affected by parotid gland carcinomas surgically treated at our Institution. Forty-four ACC were included in this study. Multivariate analysis risk models were built to predict recurrence free probability (RFP), distant recurrence free probability (DRFP), overall survival (OS) and disease free survival (DFS).
RESULTS: Twenty-one patients (47.7%) died from ACC and 2.3% for other causes. The 41% presented local-regional recurrence, with a regional-RFP rate of 93%, and the 34% reported distant metastases (DM). The five and ten-year OS rates were 74% and 50%, respectively.
CONCLUSIONS: Recurrences were mainly influenced by the presence of perineural invasion and nerve paralysis, whilst female gender and age<50 were predictors for good prognosis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma; Mortality rate; Parotid malignancy; Poor prognosis; Prognostic factors

Mesh:

Year:  2017        PMID: 28478090     DOI: 10.1016/j.amjoto.2017.03.008

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  9 in total

1.  Nomograms predictive for oncological outcomes in malignant parotid tumours: recurrence and mortality rates of 228 patients from a single institution.

Authors:  Giuditta Mannelli; Franchi Alessandro; Fasolati Martina; Cecconi Lorenzo; Alessandra Bettiol; Alfredo Vannacci; Gallo Oreste
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-25       Impact factor: 3.236

2.  Cervical lymph node metastases in salivary gland adenoid cystic carcinoma: a systematic review and meta-analysis.

Authors:  Chunliu Ning; Tengfei Zhao; Zechen Wang; Delong Li; Yurong Kou; Shaohui Huang
Journal:  Cancer Manag Res       Date:  2018-06-22       Impact factor: 3.989

3.  Establishment and Validation of Prognostic Nomograms for Patients With Parotid Gland Adenocarcinoma Not Otherwise Specified: A SEER Analysis From 2004 to 2016.

Authors:  Zi-Meng Wang; Zuo-Lin Xiang
Journal:  Front Surg       Date:  2022-01-11

4.  The efficacy of iodine-125 interstitial brachytherapy for the treatment of locally advanced adenoid cystic carcinoma of the base of tongue: a non-surgical approach.

Authors:  Shuang Dong; Wei Li; Yan Shi; Xiao-Ming Lv; Ming-Wei Huang; Jian-Guo Zhang
Journal:  J Contemp Brachytherapy       Date:  2021-08-24

5.  Clinico-Epidemiological Analysis of Most Prevalent Parotid Gland Carcinomas in Poland over a 20-Year Period.

Authors:  Michał Żurek; Kamil Jasak; Karolina Jaros; Piotr Daniel; Kazimierz Niemczyk; Anna Rzepakowska
Journal:  Int J Environ Res Public Health       Date:  2022-08-18       Impact factor: 4.614

6.  Occult neck metastases risk factors and the role of elective neck dissection in cT3-4N0 adenoid cystic carcinoma of the parotid gland.

Authors:  Junhui Yuan; Fan Meng; Chunmiao Xu; Wenlu Li; Shuang Wu; Hailiang Li
Journal:  Front Oncol       Date:  2022-09-26       Impact factor: 5.738

Review 7.  Estimating survival after salvage surgery for recurrent salivary gland cancers: Systematic review.

Authors:  Giuditta Mannelli; Lara V Comini; Andrea Sacchetto; Roberto Santoro; Giuseppe Spinelli; Pierluigi Bonomo; Isacco Desideri; Paolo Bossi; Ester Orlandi; Giammarco Alderotti; Alessandro Franchi; Annarita Palomba; Albino Eccher; Daniele Marchioni; Riccardo Nocini; Cesare Piazza; Gabriele Molteni
Journal:  Head Neck       Date:  2022-04-20       Impact factor: 3.821

8.  Spinal Metastases from Adenoid Cystic Carcinoma of the Parotid Gland.

Authors:  Shu-Zhong Liu; Xi Zhou; An Song; Zhen Huo; Jing Zhang; Yi-Peng Wang; Yong Liu
Journal:  Chin Med J (Engl)       Date:  2018-11-05       Impact factor: 2.628

9.  Pretherapeutic Serum Albumin as an Outcome Prognosticator in Head and Neck Adenoid-Cystic Carcinoma.

Authors:  Marlene Friedl; Stefan Stoiber; Faris F Brkic; Lorenz Kadletz-Wanke
Journal:  Biomedicines       Date:  2022-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.